India advances homoeopathy globally with new quality standards and growing exports.

India is emerging as a global leader in homoeopathy, bolstered by over 250,000 practitioners, 300 teaching institutions, and widespread patient use. New quality certifications—the AYUSH Premium Mark and NABL accreditation—align Indian production with international standards, enhancing safety, manufacturing quality, and global credibility. Adven Biotech became the first Indian company to earn both, signaling a shift toward scientific validation and compliance. These standards help India compete with established European brands, especially in regulated markets, as exports to over 100 countries are expected to grow significantly.